These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18390814)

  • 1. Reproductive hormones and skeletal health in young women.
    Ott SM
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1175-7. PubMed ID: 18390814
    [No Abstract]   [Full Text] [Related]  

  • 2. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report.
    Harkins GJ; Davis GD; Dettori J; Hibbert ML; Hoyt RA
    J Reprod Med; 1999 Mar; 44(3):309-12. PubMed ID: 10202754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density and depot medroxyprogesterone acetate.
    Albertazzi P; Bottazzi M; Steel SA
    Contraception; 2006 Jun; 73(6):577-83. PubMed ID: 16730487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removing the black box warning for depot medroxyprogesterone acetate.
    Kaunitz AM; Grimes DA
    Contraception; 2011 Sep; 84(3):212-3. PubMed ID: 21843682
    [No Abstract]   [Full Text] [Related]  

  • 5. ACOG Committee Opinion No. 415: Depot medroxyprogesterone acetate and bone effects.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
    Obstet Gynecol; 2008 Sep; 112(3):727-30. PubMed ID: 18757687
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of injectable depot medroxyprogesterone acetate in lactating Indian women.
    Sathyamala C; Shah P; Jain Y; Bhargava A
    Lancet; 1994 Jul; 344(8915):134-5. PubMed ID: 7912374
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone mineral density in women using depot medroxyprogesterone acetate for contraception.
    Scholes D; Lacroix AZ; Ott SM; Ichikawa LE; Barlow WE
    Obstet Gynecol; 1999 Feb; 93(2):233-8. PubMed ID: 9932562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormones and bone health in postmenopausal women.
    Lindsay R
    Endocrine; 2004 Aug; 24(3):223-30. PubMed ID: 15542889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind randomised controlled trial of the effects of medroxyprogesterone acetate on bone density of women taking oestrogen replacement therapy.
    Adachi JD; Sargeant EJ; Sagle MA; Lamont D; Fawcett PD; Bensen WG; McQueen M; Nazir DJ; Goldsmith CH
    Br J Obstet Gynaecol; 1997 Jan; 104(1):64-70. PubMed ID: 8988699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depot medroxyprogesterone acetate and bone mineral density in adolescents--the Black Box Warning: a Position Paper of the Society for Adolescent Medicine.
    Cromer BA; Scholes D; Berenson A; Cundy T; Clark MK; Kaunitz AM;
    J Adolesc Health; 2006 Aug; 39(2):296-301. PubMed ID: 16857545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroidal contraceptives: effect on bone fractures in women.
    Lopez LM; Grimes DA; Schulz KF; Curtis KM
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006033. PubMed ID: 19370623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
    Viola AS; Castro S; Bahamondes MV; Fernandes A; Viola CF; Bahamondes L
    Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of depot-medroxyprogesterone acetate in contraception and its potential impact on skeletal health.
    Guilbert ER; Brown JP; Kaunitz AM; Wagner MS; Bérubé J; Charbonneau L; Francoeur D; Gilbert A; Gilbert F; Roy G; Senikas V; Jacob R; Morin R
    Contraception; 2009 Mar; 79(3):167-77. PubMed ID: 19185668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study examining short-term changes in bone mineral density among class 3 obese users of depot-medroxyprogesterone acetate.
    Segall-Gutierrez P; Agarwal R; Ge M; Lopez C; Hernandez G; Stanczyk FZ
    Eur J Contracept Reprod Health Care; 2013 Jun; 18(3):199-205. PubMed ID: 23530919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone density recovery after depot medroxyprogesterone acetate injectable contraception use.
    Kaunitz AM; Arias R; McClung M
    Contraception; 2008 Feb; 77(2):67-76. PubMed ID: 18226668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depot medroxyprogesterone acetate contraceptive injections and skeletal health.
    Renner RM; Edelman AB; Kaunitz AM
    Womens Health (Lond); 2010 May; 6(3):339-42. PubMed ID: 20426597
    [No Abstract]   [Full Text] [Related]  

  • 17. New perspectives on the skeletal role of estrogen.
    Marcus R
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2236-8. PubMed ID: 9661588
    [No Abstract]   [Full Text] [Related]  

  • 18. Steroidal contraceptives: effect on bone fractures in women.
    Lopez LM; Grimes DA; Schulz KF; Curtis KM
    Cochrane Database Syst Rev; 2011 Jul; (7):CD006033. PubMed ID: 21735401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between caffeine intake and bone mass among young women: potential effect modification by depot medroxyprogesterone acetate use.
    Wetmore CM; Ichikawa L; LaCroix AZ; Ott SM; Scholes D
    Osteoporos Int; 2008 Apr; 19(4):519-27. PubMed ID: 18004611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroidal contraceptives: effect on bone fractures in women.
    Lopez LM; Grimes DA; Schulz KF; Curtis KM; Chen M
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006033. PubMed ID: 24960023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.